Trulieve Cannabis Corp Financials

TCNNF

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Trulieve Cannabis Corp (TCNNF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 69/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Trulieve Cannabis Corp has an operating margin of 8.2%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 41/100, indicating healthy but not exceptional operating efficiency. This is up from -19.6% the prior year.

Growth

Trulieve Cannabis Corp's revenue grew 5.1% year-over-year to $1.2B, a solid pace of expansion. This earns a growth score of 43/100.

Leverage

100

Trulieve Cannabis Corp carries a low D/E ratio of 0.29, meaning only $0.29 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 4.37, Trulieve Cannabis Corp holds $4.37 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

Trulieve Cannabis Corp has a free cash flow margin of 12.6%, earning a moderate score of 63/100. The company generates positive cash flow after capital investments, but with room for improvement.

Altman Z-Score Distress

0.83

Trulieve Cannabis Corp scores 0.83, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.3B) relative to total liabilities ($1.6B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Neutral

6/9

Trulieve Cannabis Corp passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-1.69x

For every $1 of reported earnings, Trulieve Cannabis Corp generates $-1.69 in operating cash flow ($271.5M OCF vs -$160.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

1.6x

Trulieve Cannabis Corp earns $1.6 in operating income for every $1 of interest expense ($97.8M vs $62.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Revenue

$1.2B

YoY+5.1%

5Y CAGR+36.2%

Trulieve Cannabis Corp generated $1.2B in revenue in fiscal year 2024. This represents an increase of 5.1% from the prior year.

EBITDA

$210.6M

YoY+288.4%

5Y CAGR+12.2%

Trulieve Cannabis Corp's EBITDA was $210.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 288.4% from the prior year.

Free Cash Flow

$150.0M

YoY-7.1%

Trulieve Cannabis Corp generated $150.0M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 7.1% from the prior year.

Net Income

-$160.6M

YoY+69.9%

Trulieve Cannabis Corp reported -$160.6M in net income in fiscal year 2024. This represents an increase of 69.9% from the prior year.

EPS (Diluted)

$-0.79

YoY+65.4%

Trulieve Cannabis Corp earned $-0.79 per diluted share (EPS) in fiscal year 2024. This represents an increase of 65.4% from the prior year.

Cash & Debt

$238.8M

YoY+18.6%

5Y CAGR+21.1%

Trulieve Cannabis Corp held $238.8M in cash against $364.8M in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

191M

YoY+2.6%

Trulieve Cannabis Corp had 191M shares outstanding in fiscal year 2024. This represents an increase of 2.6% from the prior year.

Gross Margin

60.3%

YoY+8.2pp

5Y CAGR-15.6pp

Trulieve Cannabis Corp's gross margin was 60.3% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 8.2 percentage points from the prior year.

Operating Margin

8.2%

YoY+27.9pp

5Y CAGR-36.6pp

Trulieve Cannabis Corp's operating margin was 8.2% in fiscal year 2024, reflecting core business profitability. This is up 27.9 percentage points from the prior year.

Net Margin

-13.5%

YoY+33.7pp

5Y CAGR-34.5pp

Trulieve Cannabis Corp's net profit margin was -13.5% in fiscal year 2024, showing the share of revenue converted to profit. This is up 33.7 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$121.5M

YoY+200.9%

5Y CAGR+11.1%

Trulieve Cannabis Corp invested $121.5M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 200.9% from the prior year.

TCNNF Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$1.2B+5.1%	$1.1B-7.3%	$1.2B+30.7%	$931.9M+78.7%	$521.5M+106.3%	$252.8M
Cost of Revenue	$470.7M-12.9%	$540.6M+2.2%	$529.1M+44.8%	$365.4M+170.4%	$135.1M+121.6%	$61.0M
Gross Profit	$715.7M+21.6%	$588.6M-14.6%	$689.1M+21.6%	$566.6M+46.6%	$386.4M+101.4%	$191.8M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$252.7M+73.1%	$146.0M-13.9%	$169.5M+70.4%	$99.5M+175.8%	$36.1M+156.2%	$14.1M
Operating Income	$97.8M+144.1%	-$221.6M-541.8%	$50.2M-75.4%	$204.1M-6.5%	$218.3M+92.7%	$113.3M
Interest Expense	$62.2M-23.8%	$81.6M+11.1%	$73.4M+152.1%	$29.1M+43.9%	$20.2M+123.6%	$9.1M
Income Tax	$197.6M+30.5%	$151.4M-7.4%	$163.4M+12.1%	$145.7M+54.3%	$94.5M+86.7%	$50.6M
Net Income	-$160.6M+69.9%	-$533.1M-111.0%	-$252.7M-1548.7%	$17.4M-72.3%	$63.0M+18.7%	$53.1M
EPS (Diluted)	$-0.79+65.4%	$-2.28-140.0%	$-0.95-552.4%	$0.21-60.4%	$0.53+15.2%	$0.46

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$288.2M-4.6%	$302.1M+1.5%	$297.8M-1.1%	$301.1M-0.8%	$303.4M+2.0%	$297.6M+3.7%	$287.0M+4.3%	$275.2M
Cost of Revenue	$118.3M-0.7%	$119.2M+4.0%	$114.5M+0.4%	$114.1M-6.3%	$121.8M-1.6%	$123.8M-7.0%	$133.1M+0.6%	$132.3M
Gross Profit	$169.9M-7.1%	$182.9M-0.2%	$183.2M-2.0%	$187.0M+3.0%	$181.6M+4.5%	$173.8M+13.0%	$153.9M+7.6%	$142.9M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$99.0M-2.1%	$101.1M-14.9%	$118.8M+219.0%	-$99.8M-197.3%	$102.6M+1.3%	$101.3M+171.4%	$37.3M+8.3%	$34.5M
Operating Income	$42.2M-19.8%	$52.6M+57.9%	$33.3M+2447.9%	$1.3M-97.4%	$49.8M+7.9%	$46.1M+58.0%	$29.2M+25.0%	$23.3M
Interest Expense	$16.1M-1.9%	$16.4M+0.6%	$16.3M+11.5%	$14.6M-5.4%	$15.4M+5.3%	$14.7M-28.9%	$20.6M-0.9%	$20.8M
Income Tax	$53.0M-3.1%	$54.7M+4.3%	$52.5M+10.3%	$47.6M+0.8%	$47.2M-14.9%	$55.4M+22.0%	$45.4M+24.0%	$36.6M
Net Income	-$28.8M-78.7%	-$16.1M+52.3%	-$33.8M+46.0%	-$62.5M-421.3%	-$12.0M+51.1%	-$24.5M+26.3%	-$33.3M-28.8%	-$25.8M
EPS (Diluted)	$-0.11-57.1%	$-0.07+56.3%	$-0.16+40.7%	$-0.27-575.0%	$-0.04+75.0%	$-0.16+11.1%	$-0.18-50.0%	$-0.12

TCNNF Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$2.9B+5.2%	$2.7B-19.7%	$3.4B-0.3%	$3.4B+321.2%	$809.8M	N/A
Current Assets	$604.6M+26.6%	$477.3M-19.6%	$593.5M+13.2%	$524.4M+100.6%	$261.5M	N/A
Cash & Equivalents	$238.8M+18.6%	$201.4M-2.8%	$207.2M-8.6%	$226.6M+54.5%	$146.7M+59.8%	$91.8M
Inventory	$231.4M+8.6%	$213.1M-22.9%	$276.5M+30.3%	$212.2M+115.8%	$98.3M	N/A
Accounts Receivable	$8.3M+23.6%	$6.7M+3.0%	$6.5M-26.5%	$8.9M+2774.7%	$308K	N/A
Goodwill	$483.9M0.0%	$483.9M-38.9%	$791.5M+3.4%	$765.4M+1039.3%	$67.2M+818.2%	$7.3M
Total Liabilities	$1.6B+22.8%	$1.3B-10.3%	$1.5B+16.6%	$1.3B+249.2%	$361.9M	N/A
Current Liabilities	$138.5M+20.6%	$114.8M-45.4%	$210.3M+24.5%	$168.9M+121.9%	$76.1M	N/A
Long-Term Debt	$364.8M+0.4%	$363.2M-32.9%	$541.7M+17.0%	$462.9M	N/A	N/A
Total Equity	$1.2B-11.3%	$1.4B-26.9%	$1.9B-10.2%	$2.1B+379.4%	$447.9M+237.1%	$132.9M
Retained Earnings	-$795.7M-24.2%	-$640.6M-462.7%	-$113.8M-182.7%	$137.7M+15.1%	$119.7M	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$2.9B+0.7%	$2.9B+1.2%	$2.9B+0.6%	$2.9B+0.2%	$2.9B+1.6%	$2.8B+3.3%	$2.7B-1.7%	$2.8B
Current Assets	$756.4M+6.3%	$711.4M+9.5%	$649.4M+7.4%	$604.6M-4.2%	$631.1M+7.8%	$585.3M+22.6%	$477.3M-1.9%	$486.7M
Cash & Equivalents	$449.2M+14.4%	$392.6M+19.5%	$328.5M+37.5%	$238.8M-32.8%	$355.2M+10.9%	$320.3M+59.1%	$201.4M+4.8%	$192.2M
Inventory	$243.3M+0.8%	$241.5M+0.9%	$239.3M+3.4%	$231.4M+11.4%	$207.6M-0.8%	$209.4M-1.7%	$213.1M-7.3%	$229.9M
Accounts Receivable	$10.5M-2.5%	$10.8M+4.9%	$10.3M+23.8%	$8.3M+10.0%	$7.5M+27.0%	$5.9M-11.5%	$6.7M-2.7%	$6.9M
Goodwill	$483.9M0.0%	$483.9M0.0%	$483.9M0.0%	$483.9M0.0%	$483.9M0.0%	$483.9M0.0%	$483.9M0.0%	$483.9M
Total Liabilities	$1.8B+2.5%	$1.7B+2.6%	$1.7B+2.9%	$1.6B+8.9%	$1.5B+4.2%	$1.4B+8.2%	$1.3B-1.1%	$1.3B
Current Liabilities	$124.1M+0.2%	$123.8M-9.4%	$136.7M-1.3%	$138.5M+11.9%	$123.8M+5.6%	$117.2M+2.0%	$114.8M-54.4%	$251.8M
Long-Term Debt	$366.1M+0.1%	$365.7M+0.1%	$365.3M+0.1%	$364.8M+0.2%	$364.0M+0.1%	$363.6M+0.1%	$363.2M+0.1%	$362.8M
Total Equity	$1.2B-1.9%	$1.2B-0.8%	$1.2B-2.4%	$1.2B-8.9%	$1.4B-0.9%	$1.4B-1.8%	$1.4B-2.2%	$1.4B
Retained Earnings	-$869.2M-3.2%	-$842.4M-1.7%	-$828.6M-4.1%	-$795.7M-17.8%	-$675.7M-1.8%	-$663.7M-3.6%	-$640.6M-5.5%	-$607.2M

TCNNF Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$271.5M+34.5%	$201.8M+773.9%	$23.1M+79.1%	$12.9M-87.1%	$99.6M+422.4%	$19.1M
Capital Expenditures	$121.5M+200.9%	$40.4M-75.5%	$164.7M-40.3%	$275.9M+176.1%	$99.9M+39.1%	$71.8M
Free Cash Flow	$150.0M-7.1%	$161.5M+214.0%	-$141.7M+46.1%	-$263.0M-88156.4%	-$298K+99.4%	-$52.8M
Investing Cash Flow	-$206.6M-451.4%	-$37.5M+82.6%	-$215.1M+0.1%	-$215.2M-23.2%	-$174.7M-84.5%	-$94.7M
Financing Cash Flow	-$33.4M+81.0%	-$175.6M-198.8%	$177.8M-38.5%	$289.2M+122.6%	$129.9M-9.1%	$143.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	$76.8M-10.8%	$86.1M+69.7%	$50.7M+65.4%	$30.7M-57.0%	$71.3M-48.7%	$139.2M+5.8%	$131.5M+40.7%	$93.4M
Capital Expenditures	$12.3M+6.6%	$11.6M-31.5%	$16.9M-59.4%	$41.6M+58.3%	$26.3M+69.7%	$15.5M+65.1%	$9.4M+49.5%	$6.3M
Free Cash Flow	$64.4M-13.5%	$74.5M+120.1%	$33.9M+409.4%	-$10.9M-124.3%	$45.0M-63.6%	$123.7M+1.3%	$122.1M+40.1%	$87.2M
Investing Cash Flow	-$15.4M-78.2%	-$8.6M-119.9%	$43.4M+287.3%	-$23.2M+29.7%	-$33.0M-73.9%	-$19.0M-164.7%	-$7.2M-43.5%	-$5.0M
Financing Cash Flow	-$4.8M+18.2%	-$5.8M-29.7%	-$4.5M+29.2%	-$6.4M+30.7%	-$9.2M-490.3%	-$1.6M+98.6%	-$115.0M-124.3%	-$51.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

TCNNF Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	60.3%+8.2pp	52.1%-4.4pp	56.6%-4.2pp	60.8%-13.3pp	74.1%-1.8pp	75.9%
Operating Margin	8.2%+27.9pp	-19.6%-23.8pp	4.1%-17.8pp	21.9%-20.0pp	41.9%-2.9pp	44.8%
Net Margin	-13.5%+33.7pp	-47.2%-26.5pp	-20.8%-22.6pp	1.9%-10.2pp	12.1%-8.9pp	21.0%
Return on Equity	N/A	N/A	N/A	0.8%-13.3pp	14.1%-25.9pp	40.0%
Return on Assets	-5.6%+13.9pp	-19.5%-12.1pp	-7.4%-7.9pp	0.5%-7.3pp	7.8%	N/A
Current Ratio	4.37+0.2	4.16+1.3	2.82-0.3	3.10-0.3	3.43	N/A
Debt-to-Equity	0.29+0.0	0.26-0.0	0.28+0.1	0.22-0.6	0.81	N/A
FCF Margin	12.6%-1.7pp	14.3%+25.9pp	-11.6%+16.6pp	-28.2%-28.2pp	-0.1%+20.8pp	-20.9%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	58.9%-1.6pp	60.6%-1.0pp	61.5%-0.6pp	62.1%+2.2pp	59.9%+1.5pp	58.4%+4.8pp	53.6%+1.7pp	51.9%
Operating Margin	14.7%-2.8pp	17.4%+6.2pp	11.2%+10.8pp	0.4%-16.0pp	16.4%+0.9pp	15.5%+5.3pp	10.2%+1.7pp	8.5%
Net Margin	-10.0%-4.7pp	-5.3%+6.0pp	-11.3%+9.4pp	-20.8%-16.8pp	-4.0%+4.3pp	-8.2%+3.4pp	-11.6%-2.2pp	-9.4%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-1.0%-0.4pp	-0.5%+0.6pp	-1.2%+1.0pp	-2.2%-1.8pp	-0.4%+0.4pp	-0.9%+0.4pp	-1.2%-0.3pp	-0.9%
Current Ratio	6.09+0.3	5.74+1.0	4.75+0.4	4.37-0.7	5.10+0.1	4.99+0.8	4.16+2.2	1.93
Debt-to-Equity	0.310.0	0.300.0	0.300.0	0.29+0.0	0.270.0	0.260.0	0.260.0	0.25
FCF Margin	22.4%-2.3pp	24.7%+13.3pp	11.4%+15.0pp	-3.6%-18.5pp	14.8%-26.7pp	41.5%-1.0pp	42.5%+10.9pp	31.7%

Similar Companies

Green Thum GTBIF

$1.7B

Nika Pharmaceuticals NIKA

$982.7M

Curaleaf Hldgs CURLF

$1.9B

Endo Inc NDOI

$1.8B

Evotec Se EVOTF

$1.3B

Frequently Asked Questions

What is Trulieve Cannabis Corp's annual revenue?

Trulieve Cannabis Corp (TCNNF) reported $1.2B in total revenue for fiscal year 2024. This represents a 5.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Trulieve Cannabis Corp's revenue growing?

Trulieve Cannabis Corp (TCNNF) revenue grew by 5.1% year-over-year, from $1.1B to $1.2B in fiscal year 2024.

Is Trulieve Cannabis Corp profitable?

No, Trulieve Cannabis Corp (TCNNF) reported a net income of -$160.6M in fiscal year 2024, with a net profit margin of -13.5%.

What is Trulieve Cannabis Corp's earnings per share (EPS)?

Trulieve Cannabis Corp (TCNNF) reported diluted earnings per share of $-0.79 for fiscal year 2024. This represents a 65.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Trulieve Cannabis Corp's EBITDA?

Trulieve Cannabis Corp (TCNNF) had EBITDA of $210.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Trulieve Cannabis Corp have?

As of fiscal year 2024, Trulieve Cannabis Corp (TCNNF) had $238.8M in cash and equivalents against $364.8M in long-term debt.

What is Trulieve Cannabis Corp's gross margin?

Trulieve Cannabis Corp (TCNNF) had a gross margin of 60.3% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Trulieve Cannabis Corp's operating margin?

Trulieve Cannabis Corp (TCNNF) had an operating margin of 8.2% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Trulieve Cannabis Corp's net profit margin?

Trulieve Cannabis Corp (TCNNF) had a net profit margin of -13.5% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Trulieve Cannabis Corp's free cash flow?

Trulieve Cannabis Corp (TCNNF) generated $150.0M in free cash flow during fiscal year 2024. This represents a -7.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Trulieve Cannabis Corp's operating cash flow?

Trulieve Cannabis Corp (TCNNF) generated $271.5M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Trulieve Cannabis Corp's total assets?

Trulieve Cannabis Corp (TCNNF) had $2.9B in total assets as of fiscal year 2024, including both current and long-term assets.

What are Trulieve Cannabis Corp's capital expenditures?

Trulieve Cannabis Corp (TCNNF) invested $121.5M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does Trulieve Cannabis Corp have outstanding?

Trulieve Cannabis Corp (TCNNF) had 191M shares outstanding as of fiscal year 2024.

What is Trulieve Cannabis Corp's current ratio?

Trulieve Cannabis Corp (TCNNF) had a current ratio of 4.37 as of fiscal year 2024, which is generally considered healthy.

What is Trulieve Cannabis Corp's debt-to-equity ratio?

Trulieve Cannabis Corp (TCNNF) had a debt-to-equity ratio of 0.29 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Trulieve Cannabis Corp's return on assets (ROA)?

Trulieve Cannabis Corp (TCNNF) had a return on assets of -5.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Trulieve Cannabis Corp's Altman Z-Score?

Trulieve Cannabis Corp (TCNNF) has an Altman Z-Score of 0.83, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Trulieve Cannabis Corp's Piotroski F-Score?

Trulieve Cannabis Corp (TCNNF) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Trulieve Cannabis Corp's earnings high quality?

Trulieve Cannabis Corp (TCNNF) has an earnings quality ratio of -1.69x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Trulieve Cannabis Corp cover its interest payments?

Trulieve Cannabis Corp (TCNNF) has an interest coverage ratio of 1.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Trulieve Cannabis Corp?

Trulieve Cannabis Corp (TCNNF) scores 69 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.